nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—Phenylpropanolamine—obesity	0.125	0.384	CrCtD
Pseudoephedrine—Phentermine—obesity	0.107	0.326	CrCtD
Pseudoephedrine—Methamphetamine—obesity	0.095	0.291	CrCtD
Pseudoephedrine—ADRB1—obesity	0.0369	0.281	CbGaD
Pseudoephedrine—TNF—obesity	0.035	0.267	CbGaD
Pseudoephedrine—ADRB2—obesity	0.0311	0.237	CbGaD
Pseudoephedrine—SLC6A4—obesity	0.0282	0.215	CbGaD
Pseudoephedrine—Etomidate—Diethylpropion—obesity	0.0169	0.0775	CrCrCtD
Pseudoephedrine—SLC6A3—Diethylpropion—obesity	0.014	0.0608	CbGbCtD
Pseudoephedrine—MAOA—Phentermine—obesity	0.0119	0.0516	CbGbCtD
Pseudoephedrine—Metaraminol—Phenylpropanolamine—obesity	0.0119	0.0544	CrCrCtD
Pseudoephedrine—MAOA—Phenylpropanolamine—obesity	0.0113	0.0493	CbGbCtD
Pseudoephedrine—SLC6A3—Sibutramine—obesity	0.0106	0.0461	CbGbCtD
Pseudoephedrine—SLC6A3—Phendimetrazine—obesity	0.0106	0.0461	CbGbCtD
Pseudoephedrine—SLC6A2—Diethylpropion—obesity	0.0102	0.0445	CbGbCtD
Pseudoephedrine—MAOA—Methamphetamine—obesity	0.0095	0.0413	CbGbCtD
Pseudoephedrine—SLC6A4—Sibutramine—obesity	0.00928	0.0403	CbGbCtD
Pseudoephedrine—Isoxsuprine—Phenylpropanolamine—obesity	0.00885	0.0405	CrCrCtD
Pseudoephedrine—SLC6A3—Benzphetamine—obesity	0.00804	0.0349	CbGbCtD
Pseudoephedrine—SLC6A3—Phentermine—obesity	0.00804	0.0349	CbGbCtD
Pseudoephedrine—SLC6A2—Sibutramine—obesity	0.00776	0.0337	CbGbCtD
Pseudoephedrine—SLC6A2—Phendimetrazine—obesity	0.00776	0.0337	CbGbCtD
Pseudoephedrine—SLC6A3—Phenylpropanolamine—obesity	0.00767	0.0333	CbGbCtD
Pseudoephedrine—Ephedrine—Phenylpropanolamine—obesity	0.00749	0.0343	CrCrCtD
Pseudoephedrine—Selegiline—Diethylpropion—obesity	0.00735	0.0337	CrCrCtD
Pseudoephedrine—Phenylpropanolamine—Phentermine—obesity	0.00709	0.0325	CrCrCtD
Pseudoephedrine—SLC6A4—Phentermine—obesity	0.00703	0.0306	CbGbCtD
Pseudoephedrine—SLC6A3—Bupropion—obesity	0.00684	0.0297	CbGbCtD
Pseudoephedrine—ADRB2—Phenylpropanolamine—obesity	0.00671	0.0292	CbGbCtD
Pseudoephedrine—ADRA1A—Phendimetrazine—obesity	0.00671	0.0292	CbGbCtD
Pseudoephedrine—ADRB1—Phenylpropanolamine—obesity	0.00661	0.0287	CbGbCtD
Pseudoephedrine—Phenol—Phenylpropanolamine—obesity	0.00653	0.0299	CrCrCtD
Pseudoephedrine—SLC6A3—Methamphetamine—obesity	0.00643	0.0279	CbGbCtD
Pseudoephedrine—Ephedrine—Phentermine—obesity	0.00637	0.0292	CrCrCtD
Pseudoephedrine—Phenylpropanolamine—Methamphetamine—obesity	0.00632	0.0289	CrCrCtD
Pseudoephedrine—Selegiline—Phentermine—obesity	0.00607	0.0278	CrCrCtD
Pseudoephedrine—Phentermine—Phenylpropanolamine—obesity	0.00603	0.0276	CrCrCtD
Pseudoephedrine—SLC6A2—Benzphetamine—obesity	0.00588	0.0256	CbGbCtD
Pseudoephedrine—SLC6A2—Phentermine—obesity	0.00588	0.0256	CbGbCtD
Pseudoephedrine—Bethanidine—Phentermine—obesity	0.0058	0.0266	CrCrCtD
Pseudoephedrine—Ephedrine—Methamphetamine—obesity	0.00568	0.026	CrCrCtD
Pseudoephedrine—SLC6A4—Methamphetamine—obesity	0.00562	0.0244	CbGbCtD
Pseudoephedrine—SLC6A2—Phenylpropanolamine—obesity	0.00561	0.0244	CbGbCtD
Pseudoephedrine—Benzyl alcohol—Phenylpropanolamine—obesity	0.00561	0.0257	CrCrCtD
Pseudoephedrine—Phenol—Phentermine—obesity	0.00555	0.0254	CrCrCtD
Pseudoephedrine—Mephentermine—Phentermine—obesity	0.00555	0.0254	CrCrCtD
Pseudoephedrine—Selegiline—Methamphetamine—obesity	0.00541	0.0248	CrCrCtD
Pseudoephedrine—ADRA2A—Benzphetamine—obesity	0.0053	0.0231	CbGbCtD
Pseudoephedrine—Bethanidine—Methamphetamine—obesity	0.00517	0.0237	CrCrCtD
Pseudoephedrine—ADRA1A—Benzphetamine—obesity	0.00509	0.0221	CbGbCtD
Pseudoephedrine—Amphetamine—Diethylpropion—obesity	0.00508	0.0233	CrCrCtD
Pseudoephedrine—Dextroamphetamine—Diethylpropion—obesity	0.00508	0.0233	CrCrCtD
Pseudoephedrine—ADRA2A—Phenylpropanolamine—obesity	0.00506	0.022	CbGbCtD
Pseudoephedrine—SLC6A2—Bupropion—obesity	0.005	0.0217	CbGbCtD
Pseudoephedrine—Mephentermine—Methamphetamine—obesity	0.00495	0.0227	CrCrCtD
Pseudoephedrine—Phenol—Methamphetamine—obesity	0.00495	0.0227	CrCrCtD
Pseudoephedrine—Methamphetamine—Diethylpropion—obesity	0.00493	0.0226	CrCrCtD
Pseudoephedrine—Amphetamine—Phenylpropanolamine—obesity	0.00493	0.0226	CrCrCtD
Pseudoephedrine—Dextroamphetamine—Phenylpropanolamine—obesity	0.00493	0.0226	CrCrCtD
Pseudoephedrine—ADRA1A—Phenylpropanolamine—obesity	0.00485	0.0211	CbGbCtD
Pseudoephedrine—Methamphetamine—Phenylpropanolamine—obesity	0.00479	0.0219	CrCrCtD
Pseudoephedrine—Benzyl alcohol—Phentermine—obesity	0.00477	0.0218	CrCrCtD
Pseudoephedrine—SLC6A2—Methamphetamine—obesity	0.0047	0.0204	CbGbCtD
Pseudoephedrine—Phentermine—Methamphetamine—obesity	0.00457	0.0209	CrCrCtD
Pseudoephedrine—Selegiline—Benzphetamine—obesity	0.00429	0.0196	CrCrCtD
Pseudoephedrine—Benzyl alcohol—Methamphetamine—obesity	0.00425	0.0195	CrCrCtD
Pseudoephedrine—ADRA2A—Methamphetamine—obesity	0.00424	0.0184	CbGbCtD
Pseudoephedrine—Dextroamphetamine—Phentermine—obesity	0.00419	0.0192	CrCrCtD
Pseudoephedrine—Amphetamine—Phentermine—obesity	0.00419	0.0192	CrCrCtD
Pseudoephedrine—Methamphetamine—Phentermine—obesity	0.00407	0.0186	CrCrCtD
Pseudoephedrine—Amphetamine—Methamphetamine—obesity	0.00374	0.0171	CrCrCtD
Pseudoephedrine—Dextroamphetamine—Methamphetamine—obesity	0.00374	0.0171	CrCrCtD
Pseudoephedrine—Dextroamphetamine—Benzphetamine—obesity	0.00296	0.0136	CrCrCtD
Pseudoephedrine—Amphetamine—Benzphetamine—obesity	0.00296	0.0136	CrCrCtD
Pseudoephedrine—Methamphetamine—Benzphetamine—obesity	0.00288	0.0132	CrCrCtD
Pseudoephedrine—Atomoxetine—Benzphetamine—obesity	0.00246	0.0113	CrCrCtD
Pseudoephedrine—CYP2D6—Phentermine—obesity	0.00176	0.00767	CbGbCtD
Pseudoephedrine—CYP2D6—Bupropion—obesity	0.0015	0.00652	CbGbCtD
Pseudoephedrine—CYP2D6—Methamphetamine—obesity	0.00141	0.00613	CbGbCtD
Pseudoephedrine—CYP2D6—Cimetidine—obesity	0.0011	0.00478	CbGbCtD
Pseudoephedrine—SLC6A2—sympathetic nervous system—obesity	0.00103	0.089	CbGeAlD
Pseudoephedrine—IL2—respiratory system—obesity	0.000839	0.0722	CbGeAlD
Pseudoephedrine—NFATC1—cardiovascular system—obesity	0.000703	0.0604	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—obesity	0.000695	0.0598	CbGeAlD
Pseudoephedrine—IL2—cardiovascular system—obesity	0.000643	0.0553	CbGeAlD
Pseudoephedrine—NFATC1—adipose tissue—obesity	0.00062	0.0533	CbGeAlD
Pseudoephedrine—NFATC1—adrenal gland—obesity	0.000556	0.0478	CbGeAlD
Pseudoephedrine—IL2—digestive system—obesity	0.000533	0.0459	CbGeAlD
Pseudoephedrine—IL2—endocrine gland—obesity	0.000441	0.0379	CbGeAlD
Pseudoephedrine—IL2—liver—obesity	0.000397	0.0342	CbGeAlD
Pseudoephedrine—SLC6A3—hindbrain—obesity	0.000363	0.0312	CbGeAlD
Pseudoephedrine—SLC6A4—hindbrain—obesity	0.000333	0.0286	CbGeAlD
Pseudoephedrine—Cyclandelate—CES1—obesity	0.000313	0.267	CrCbGaD
Pseudoephedrine—Psychotic disorder—Phenylpropanolamine—obesity	0.000312	0.00792	CcSEcCtD
Pseudoephedrine—Irritability—Phenylpropanolamine—obesity	0.000305	0.00774	CcSEcCtD
Pseudoephedrine—Urinary retention—Phenylpropanolamine—obesity	0.000304	0.00771	CcSEcCtD
Pseudoephedrine—Sweating—Benzphetamine—obesity	0.000303	0.0077	CcSEcCtD
Pseudoephedrine—Dysuria—Phendimetrazine—obesity	0.000303	0.00767	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Phentermine—obesity	0.000299	0.00758	CcSEcCtD
Pseudoephedrine—Sweating—Phendimetrazine—obesity	0.000277	0.00702	CcSEcCtD
Pseudoephedrine—ADRA1A—hindbrain—obesity	0.000272	0.0234	CbGeAlD
Pseudoephedrine—MAOA—hindbrain—obesity	0.00027	0.0232	CbGeAlD
Pseudoephedrine—Psychotic disorder—Diethylpropion—obesity	0.00026	0.00659	CcSEcCtD
Pseudoephedrine—Angina pectoris—Phentermine—obesity	0.000258	0.00653	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Cimetidine—obesity	0.000247	0.00627	CcSEcCtD
Pseudoephedrine—Ventricular fibrillation—Sibutramine—obesity	0.000243	0.00618	CcSEcCtD
Pseudoephedrine—Urinary retention—Cimetidine—obesity	0.000241	0.00611	CcSEcCtD
Pseudoephedrine—Tremor—Methamphetamine—obesity	0.00024	0.0061	CcSEcCtD
Pseudoephedrine—Paranoia—Bupropion—obesity	0.000238	0.00605	CcSEcCtD
Pseudoephedrine—Agitation—Methamphetamine—obesity	0.000236	0.00598	CcSEcCtD
Pseudoephedrine—Tremor—Benzphetamine—obesity	0.000232	0.00588	CcSEcCtD
Pseudoephedrine—Agitation—Benzphetamine—obesity	0.000227	0.00577	CcSEcCtD
Pseudoephedrine—Palpitations—Methamphetamine—obesity	0.000227	0.00575	CcSEcCtD
Pseudoephedrine—SLC6A3—respiratory system—obesity	0.000222	0.0191	CbGeAlD
Pseudoephedrine—Hallucination—Phenylpropanolamine—obesity	0.00022	0.00558	CcSEcCtD
Pseudoephedrine—Palpitations—Benzphetamine—obesity	0.000219	0.00554	CcSEcCtD
Pseudoephedrine—Dysuria—Diethylpropion—obesity	0.000215	0.00546	CcSEcCtD
Pseudoephedrine—Tremor—Phendimetrazine—obesity	0.000211	0.00536	CcSEcCtD
Pseudoephedrine—Hallucination—Phentermine—obesity	0.000211	0.00534	CcSEcCtD
Pseudoephedrine—Agitation—Phendimetrazine—obesity	0.000207	0.00525	CcSEcCtD
Pseudoephedrine—Tachycardia—Methamphetamine—obesity	0.000204	0.00518	CcSEcCtD
Pseudoephedrine—Amphetamine—CARTPT—obesity	0.000203	0.173	CrCbGaD
Pseudoephedrine—SLC6A4—respiratory system—obesity	0.000203	0.0175	CbGeAlD
Pseudoephedrine—Palpitations—Phendimetrazine—obesity	0.000199	0.00505	CcSEcCtD
Pseudoephedrine—Arrhythmia—Phenylpropanolamine—obesity	0.000198	0.00501	CcSEcCtD
Pseudoephedrine—Tachycardia—Benzphetamine—obesity	0.000197	0.005	CcSEcCtD
Pseudoephedrine—Pallor—Bupropion—obesity	0.000196	0.00497	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Benzphetamine—obesity	0.000195	0.00495	CcSEcCtD
Pseudoephedrine—Extrasystoles—Bupropion—obesity	0.000193	0.0049	CcSEcCtD
Pseudoephedrine—Anorexia—Benzphetamine—obesity	0.000192	0.00488	CcSEcCtD
Pseudoephedrine—Insomnia—Methamphetamine—obesity	0.000189	0.0048	CcSEcCtD
Pseudoephedrine—Tension—Phenylpropanolamine—obesity	0.000189	0.00479	CcSEcCtD
Pseudoephedrine—Delirium—Bupropion—obesity	0.000189	0.00479	CcSEcCtD
Pseudoephedrine—Nervousness—Phenylpropanolamine—obesity	0.000187	0.00474	CcSEcCtD
Pseudoephedrine—Blood pressure increased—Sibutramine—obesity	0.000186	0.00473	CcSEcCtD
Pseudoephedrine—Dyspepsia—Methamphetamine—obesity	0.000184	0.00467	CcSEcCtD
Pseudoephedrine—Insomnia—Benzphetamine—obesity	0.000183	0.00463	CcSEcCtD
Pseudoephedrine—Tension—Phentermine—obesity	0.000181	0.00459	CcSEcCtD
Pseudoephedrine—Tremor—Phenylpropanolamine—obesity	0.00018	0.00458	CcSEcCtD
Pseudoephedrine—Tachycardia—Phendimetrazine—obesity	0.00018	0.00455	CcSEcCtD
Pseudoephedrine—Nervousness—Phentermine—obesity	0.000179	0.00454	CcSEcCtD
Pseudoephedrine—SLC6A2—respiratory system—obesity	0.000179	0.0154	CbGeAlD
Pseudoephedrine—Bradycardia—Cimetidine—obesity	0.000178	0.00452	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Phendimetrazine—obesity	0.000178	0.00451	CcSEcCtD
Pseudoephedrine—Dyspepsia—Benzphetamine—obesity	0.000178	0.00451	CcSEcCtD
Pseudoephedrine—Agitation—Phenylpropanolamine—obesity	0.000177	0.00449	CcSEcCtD
Pseudoephedrine—Decreased appetite—Benzphetamine—obesity	0.000175	0.00445	CcSEcCtD
Pseudoephedrine—Anorexia—Phendimetrazine—obesity	0.000175	0.00445	CcSEcCtD
Pseudoephedrine—MAOA—islet of Langerhans—obesity	0.000175	0.015	CbGeAlD
Pseudoephedrine—Hallucination—Cimetidine—obesity	0.000174	0.00442	CcSEcCtD
Pseudoephedrine—Tremor—Phentermine—obesity	0.000173	0.00438	CcSEcCtD
Pseudoephedrine—Agitation—Phentermine—obesity	0.000169	0.0043	CcSEcCtD
Pseudoephedrine—Insomnia—Phendimetrazine—obesity	0.000166	0.00422	CcSEcCtD
Pseudoephedrine—MAOA—respiratory system—obesity	0.000165	0.0142	CbGeAlD
Pseudoephedrine—Arrhythmia—Diethylpropion—obesity	0.000165	0.00417	CcSEcCtD
Pseudoephedrine—Anxiety—Phenylpropanolamine—obesity	0.000163	0.00414	CcSEcCtD
Pseudoephedrine—Palpitations—Phentermine—obesity	0.000163	0.00413	CcSEcCtD
Pseudoephedrine—Blood pressure increased—Bupropion—obesity	0.000163	0.00412	CcSEcCtD
Pseudoephedrine—ADRB1—cardiovascular system—obesity	0.000161	0.0139	CbGeAlD
Pseudoephedrine—CYP2D6—hindbrain—obesity	0.00016	0.0138	CbGeAlD
Pseudoephedrine—Euphoric mood—Sibutramine—obesity	0.00016	0.00406	CcSEcCtD
Pseudoephedrine—Decreased appetite—Phendimetrazine—obesity	0.00016	0.00406	CcSEcCtD
Pseudoephedrine—Hypertension—Phentermine—obesity	0.000159	0.00404	CcSEcCtD
Pseudoephedrine—Confusional state—Phenylpropanolamine—obesity	0.000158	0.00402	CcSEcCtD
Pseudoephedrine—Tension—Diethylpropion—obesity	0.000157	0.00399	CcSEcCtD
Pseudoephedrine—Chest pain—Phentermine—obesity	0.000157	0.00398	CcSEcCtD
Pseudoephedrine—Nervousness—Diethylpropion—obesity	0.000156	0.00395	CcSEcCtD
Pseudoephedrine—Tachycardia—Phenylpropanolamine—obesity	0.000153	0.00389	CcSEcCtD
Pseudoephedrine—Paranoia—Topiramate—obesity	0.000152	0.00385	CcSEcCtD
Pseudoephedrine—Tremor—Diethylpropion—obesity	0.00015	0.00381	CcSEcCtD
Pseudoephedrine—Agitation—Diethylpropion—obesity	0.000147	0.00374	CcSEcCtD
Pseudoephedrine—Tachycardia—Phentermine—obesity	0.000147	0.00372	CcSEcCtD
Pseudoephedrine—Insomnia—Phenylpropanolamine—obesity	0.000142	0.00361	CcSEcCtD
Pseudoephedrine—ADRB1—adipose tissue—obesity	0.000142	0.0122	CbGeAlD
Pseudoephedrine—Palpitations—Diethylpropion—obesity	0.000142	0.00359	CcSEcCtD
Pseudoephedrine—Atomoxetine—NPY1R—obesity	0.00014	0.12	CrCbGaD
Pseudoephedrine—Agitation—Cimetidine—obesity	0.00014	0.00356	CcSEcCtD
Pseudoephedrine—Dyspnoea—Phenylpropanolamine—obesity	0.00014	0.00355	CcSEcCtD
Pseudoephedrine—Euphoric mood—Bupropion—obesity	0.00014	0.00354	CcSEcCtD
Pseudoephedrine—Dizziness—Methamphetamine—obesity	0.000138	0.00351	CcSEcCtD
Pseudoephedrine—MAOA—adrenal cortex—obesity	0.000138	0.0119	CbGeAlD
Pseudoephedrine—Chest pain—Diethylpropion—obesity	0.000136	0.00346	CcSEcCtD
Pseudoephedrine—Insomnia—Phentermine—obesity	0.000136	0.00345	CcSEcCtD
Pseudoephedrine—Anxiety—Diethylpropion—obesity	0.000136	0.00345	CcSEcCtD
Pseudoephedrine—ADRA2A—islet of Langerhans—obesity	0.000134	0.0115	CbGeAlD
Pseudoephedrine—Dizziness—Benzphetamine—obesity	0.000133	0.00339	CcSEcCtD
Pseudoephedrine—Dyspepsia—Phentermine—obesity	0.000132	0.00336	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Sibutramine—obesity	0.000132	0.00335	CcSEcCtD
Pseudoephedrine—Headache—Methamphetamine—obesity	0.000131	0.00333	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Phenylpropanolamine—obesity	0.00013	0.00329	CcSEcCtD
Pseudoephedrine—Anxiety—Cimetidine—obesity	0.000129	0.00328	CcSEcCtD
Pseudoephedrine—SLC6A4—digestive system—obesity	0.000129	0.0111	CbGeAlD
Pseudoephedrine—Urinary retention—Sibutramine—obesity	0.000129	0.00326	CcSEcCtD
Pseudoephedrine—Tachycardia—Diethylpropion—obesity	0.000128	0.00324	CcSEcCtD
Pseudoephedrine—ADRA1A—cardiovascular system—obesity	0.000127	0.011	CbGeAlD
Pseudoephedrine—Hyperhidrosis—Diethylpropion—obesity	0.000126	0.00321	CcSEcCtD
Pseudoephedrine—Headache—Benzphetamine—obesity	0.000126	0.00321	CcSEcCtD
Pseudoephedrine—MAOA—cardiovascular system—obesity	0.000126	0.0109	CbGeAlD
Pseudoephedrine—Confusional state—Cimetidine—obesity	0.000126	0.00318	CcSEcCtD
Pseudoephedrine—Pallor—Topiramate—obesity	0.000125	0.00317	CcSEcCtD
Pseudoephedrine—Dizziness—Phendimetrazine—obesity	0.000122	0.00309	CcSEcCtD
Pseudoephedrine—Tachycardia—Cimetidine—obesity	0.000122	0.00308	CcSEcCtD
Pseudoephedrine—Delirium—Topiramate—obesity	0.00012	0.00305	CcSEcCtD
Pseudoephedrine—Nausea—Benzphetamine—obesity	0.00012	0.00304	CcSEcCtD
Pseudoephedrine—Insomnia—Diethylpropion—obesity	0.000118	0.003	CcSEcCtD
Pseudoephedrine—Dyspnoea—Diethylpropion—obesity	0.000117	0.00296	CcSEcCtD
Pseudoephedrine—Headache—Phendimetrazine—obesity	0.000115	0.00292	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Bupropion—obesity	0.000115	0.00292	CcSEcCtD
Pseudoephedrine—Dyspepsia—Diethylpropion—obesity	0.000115	0.00292	CcSEcCtD
Pseudoephedrine—Angina pectoris—Sibutramine—obesity	0.000114	0.00289	CcSEcCtD
Pseudoephedrine—Irritability—Bupropion—obesity	0.000113	0.00286	CcSEcCtD
Pseudoephedrine—ADRA1A—adipose tissue—obesity	0.000112	0.00966	CbGeAlD
Pseudoephedrine—Urinary retention—Bupropion—obesity	0.000112	0.00285	CcSEcCtD
Pseudoephedrine—MAOA—pituitary gland—obesity	0.000112	0.00961	CbGeAlD
Pseudoephedrine—MAOA—adipose tissue—obesity	0.000111	0.00957	CbGeAlD
Pseudoephedrine—ADRB1—endocrine gland—obesity	0.00011	0.0095	CbGeAlD
Pseudoephedrine—Dysuria—Sibutramine—obesity	0.000109	0.00277	CcSEcCtD
Pseudoephedrine—Nausea—Phendimetrazine—obesity	0.000109	0.00277	CcSEcCtD
Pseudoephedrine—SLC6A2—adrenal gland—obesity	0.000108	0.00932	CbGeAlD
Pseudoephedrine—Asthenia—Phentermine—obesity	0.000108	0.00274	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Diethylpropion—obesity	0.000108	0.00273	CcSEcCtD
Pseudoephedrine—SLC6A4—endocrine gland—obesity	0.000107	0.00918	CbGeAlD
Pseudoephedrine—MAOA—digestive system—obesity	0.000105	0.00901	CbGeAlD
Pseudoephedrine—Dizziness—Phenylpropanolamine—obesity	0.000104	0.00264	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Cimetidine—obesity	0.000103	0.0026	CcSEcCtD
Pseudoephedrine—ADRA1A—adrenal gland—obesity	0.000101	0.00867	CbGeAlD
Pseudoephedrine—Sweating—Sibutramine—obesity	0.0001	0.00254	CcSEcCtD
Pseudoephedrine—Vomiting—Phenylpropanolamine—obesity	9.99e-05	0.00253	CcSEcCtD
Pseudoephedrine—MAOA—adrenal gland—obesity	9.98e-05	0.00859	CbGeAlD
Pseudoephedrine—Dizziness—Phentermine—obesity	9.95e-05	0.00252	CcSEcCtD
Pseudoephedrine—Rash—Phenylpropanolamine—obesity	9.91e-05	0.00251	CcSEcCtD
Pseudoephedrine—Dermatitis—Phenylpropanolamine—obesity	9.9e-05	0.00251	CcSEcCtD
Pseudoephedrine—Body temperature increased—Cimetidine—obesity	9.84e-05	0.0025	CcSEcCtD
Pseudoephedrine—Vomiting—Phentermine—obesity	9.56e-05	0.00243	CcSEcCtD
Pseudoephedrine—Dysuria—Bupropion—obesity	9.54e-05	0.00242	CcSEcCtD
Pseudoephedrine—Bradycardia—Sibutramine—obesity	9.53e-05	0.00242	CcSEcCtD
Pseudoephedrine—Rash—Phentermine—obesity	9.48e-05	0.00241	CcSEcCtD
Pseudoephedrine—Dermatitis—Phentermine—obesity	9.47e-05	0.0024	CcSEcCtD
Pseudoephedrine—Headache—Phentermine—obesity	9.42e-05	0.00239	CcSEcCtD
Pseudoephedrine—SLC6A2—endocrine gland—obesity	9.4e-05	0.00808	CbGeAlD
Pseudoephedrine—Nausea—Phenylpropanolamine—obesity	9.34e-05	0.00237	CcSEcCtD
Pseudoephedrine—Nausea—Phentermine—obesity	8.93e-05	0.00227	CcSEcCtD
Pseudoephedrine—Asthenia—Cimetidine—obesity	8.93e-05	0.00227	CcSEcCtD
Pseudoephedrine—Euphoric mood—Topiramate—obesity	8.9e-05	0.00226	CcSEcCtD
Pseudoephedrine—ADRA1A—endocrine gland—obesity	8.74e-05	0.00751	CbGeAlD
Pseudoephedrine—Sweating—Bupropion—obesity	8.72e-05	0.00221	CcSEcCtD
Pseudoephedrine—MAOA—endocrine gland—obesity	8.66e-05	0.00745	CbGeAlD
Pseudoephedrine—Dizziness—Diethylpropion—obesity	8.65e-05	0.00219	CcSEcCtD
Pseudoephedrine—ADRA2A—pituitary gland—obesity	8.57e-05	0.00738	CbGeAlD
Pseudoephedrine—ADRA2A—adipose tissue—obesity	8.54e-05	0.00735	CbGeAlD
Pseudoephedrine—Arrhythmia—Sibutramine—obesity	8.36e-05	0.00212	CcSEcCtD
Pseudoephedrine—Vomiting—Diethylpropion—obesity	8.32e-05	0.00211	CcSEcCtD
Pseudoephedrine—Rash—Diethylpropion—obesity	8.25e-05	0.00209	CcSEcCtD
Pseudoephedrine—Dermatitis—Diethylpropion—obesity	8.24e-05	0.00209	CcSEcCtD
Pseudoephedrine—Dizziness—Cimetidine—obesity	8.23e-05	0.00209	CcSEcCtD
Pseudoephedrine—Headache—Diethylpropion—obesity	8.2e-05	0.00208	CcSEcCtD
Pseudoephedrine—Hallucination—Bupropion—obesity	8.12e-05	0.00206	CcSEcCtD
Pseudoephedrine—Muscle spasms—Orlistat—obesity	8.1e-05	0.00205	CcSEcCtD
Pseudoephedrine—Tension—Sibutramine—obesity	8e-05	0.00203	CcSEcCtD
Pseudoephedrine—Nervousness—Sibutramine—obesity	7.92e-05	0.00201	CcSEcCtD
Pseudoephedrine—Vomiting—Cimetidine—obesity	7.92e-05	0.00201	CcSEcCtD
Pseudoephedrine—ADRA1A—liver—obesity	7.88e-05	0.00678	CbGeAlD
Pseudoephedrine—Rash—Cimetidine—obesity	7.85e-05	0.00199	CcSEcCtD
Pseudoephedrine—Dermatitis—Cimetidine—obesity	7.84e-05	0.00199	CcSEcCtD
Pseudoephedrine—Muscle spasms—Sibutramine—obesity	7.84e-05	0.00199	CcSEcCtD
Pseudoephedrine—MAOA—liver—obesity	7.81e-05	0.00671	CbGeAlD
Pseudoephedrine—Headache—Cimetidine—obesity	7.8e-05	0.00198	CcSEcCtD
Pseudoephedrine—Nausea—Diethylpropion—obesity	7.77e-05	0.00197	CcSEcCtD
Pseudoephedrine—ADRA2A—adrenal gland—obesity	7.66e-05	0.00659	CbGeAlD
Pseudoephedrine—Tremor—Sibutramine—obesity	7.64e-05	0.00194	CcSEcCtD
Pseudoephedrine—Vertigo—Orlistat—obesity	7.57e-05	0.00192	CcSEcCtD
Pseudoephedrine—Agitation—Sibutramine—obesity	7.49e-05	0.0019	CcSEcCtD
Pseudoephedrine—Palpitations—Orlistat—obesity	7.44e-05	0.00189	CcSEcCtD
Pseudoephedrine—Nausea—Cimetidine—obesity	7.4e-05	0.00188	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Topiramate—obesity	7.34e-05	0.00186	CcSEcCtD
Pseudoephedrine—Vertigo—Sibutramine—obesity	7.32e-05	0.00186	CcSEcCtD
Pseudoephedrine—Arrhythmia—Bupropion—obesity	7.29e-05	0.00185	CcSEcCtD
Pseudoephedrine—Palpitations—Sibutramine—obesity	7.2e-05	0.00183	CcSEcCtD
Pseudoephedrine—Irritability—Topiramate—obesity	7.18e-05	0.00182	CcSEcCtD
Pseudoephedrine—Chest pain—Orlistat—obesity	7.17e-05	0.00182	CcSEcCtD
Pseudoephedrine—Urinary retention—Topiramate—obesity	7.15e-05	0.00181	CcSEcCtD
Pseudoephedrine—Anxiety—Orlistat—obesity	7.15e-05	0.00181	CcSEcCtD
Pseudoephedrine—Hypertension—Sibutramine—obesity	7.04e-05	0.00178	CcSEcCtD
Pseudoephedrine—Tension—Bupropion—obesity	6.97e-05	0.00177	CcSEcCtD
Pseudoephedrine—Chest pain—Sibutramine—obesity	6.94e-05	0.00176	CcSEcCtD
Pseudoephedrine—Anxiety—Sibutramine—obesity	6.92e-05	0.00175	CcSEcCtD
Pseudoephedrine—Nervousness—Bupropion—obesity	6.9e-05	0.00175	CcSEcCtD
Pseudoephedrine—Muscle spasms—Bupropion—obesity	6.83e-05	0.00173	CcSEcCtD
Pseudoephedrine—Confusional state—Sibutramine—obesity	6.71e-05	0.0017	CcSEcCtD
Pseudoephedrine—Tremor—Bupropion—obesity	6.66e-05	0.00169	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Orlistat—obesity	6.64e-05	0.00169	CcSEcCtD
Pseudoephedrine—ADRA2A—endocrine gland—obesity	6.64e-05	0.00571	CbGeAlD
Pseudoephedrine—Agitation—Bupropion—obesity	6.53e-05	0.00166	CcSEcCtD
Pseudoephedrine—Tachycardia—Sibutramine—obesity	6.49e-05	0.00165	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Sibutramine—obesity	6.43e-05	0.00163	CcSEcCtD
Pseudoephedrine—Vertigo—Bupropion—obesity	6.38e-05	0.00162	CcSEcCtD
Pseudoephedrine—Anorexia—Sibutramine—obesity	6.34e-05	0.00161	CcSEcCtD
Pseudoephedrine—Angina pectoris—Topiramate—obesity	6.33e-05	0.00161	CcSEcCtD
Pseudoephedrine—Palpitations—Bupropion—obesity	6.28e-05	0.00159	CcSEcCtD
Pseudoephedrine—CYP2D6—digestive system—obesity	6.23e-05	0.00536	CbGeAlD
Pseudoephedrine—Etomidate—CYP19A1—obesity	6.22e-05	0.0531	CrCbGaD
Pseudoephedrine—Insomnia—Orlistat—obesity	6.22e-05	0.00158	CcSEcCtD
Pseudoephedrine—Hypertension—Bupropion—obesity	6.13e-05	0.00156	CcSEcCtD
Pseudoephedrine—Dysuria—Topiramate—obesity	6.08e-05	0.00154	CcSEcCtD
Pseudoephedrine—Dyspepsia—Orlistat—obesity	6.05e-05	0.00153	CcSEcCtD
Pseudoephedrine—Chest pain—Bupropion—obesity	6.05e-05	0.00153	CcSEcCtD
Pseudoephedrine—Anxiety—Bupropion—obesity	6.03e-05	0.00153	CcSEcCtD
Pseudoephedrine—Insomnia—Sibutramine—obesity	6.02e-05	0.00153	CcSEcCtD
Pseudoephedrine—Decreased appetite—Orlistat—obesity	5.98e-05	0.00152	CcSEcCtD
Pseudoephedrine—Dyspnoea—Sibutramine—obesity	5.93e-05	0.0015	CcSEcCtD
Pseudoephedrine—Pain—Orlistat—obesity	5.88e-05	0.00149	CcSEcCtD
Pseudoephedrine—Dyspepsia—Sibutramine—obesity	5.86e-05	0.00149	CcSEcCtD
Pseudoephedrine—Confusional state—Bupropion—obesity	5.85e-05	0.00148	CcSEcCtD
Pseudoephedrine—Decreased appetite—Sibutramine—obesity	5.78e-05	0.00147	CcSEcCtD
Pseudoephedrine—Pain—Sibutramine—obesity	5.69e-05	0.00144	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Orlistat—obesity	5.66e-05	0.00144	CcSEcCtD
Pseudoephedrine—Tachycardia—Bupropion—obesity	5.66e-05	0.00144	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Bupropion—obesity	5.61e-05	0.00142	CcSEcCtD
Pseudoephedrine—Anorexia—Bupropion—obesity	5.53e-05	0.0014	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Sibutramine—obesity	5.48e-05	0.00139	CcSEcCtD
Pseudoephedrine—Body temperature increased—Orlistat—obesity	5.43e-05	0.00138	CcSEcCtD
Pseudoephedrine—Bradycardia—Topiramate—obesity	5.29e-05	0.00134	CcSEcCtD
Pseudoephedrine—Body temperature increased—Sibutramine—obesity	5.26e-05	0.00133	CcSEcCtD
Pseudoephedrine—Insomnia—Bupropion—obesity	5.25e-05	0.00133	CcSEcCtD
Pseudoephedrine—Hallucination—Topiramate—obesity	5.17e-05	0.00131	CcSEcCtD
Pseudoephedrine—Dyspnoea—Bupropion—obesity	5.17e-05	0.00131	CcSEcCtD
Pseudoephedrine—CYP2D6—endocrine gland—obesity	5.15e-05	0.00443	CbGeAlD
Pseudoephedrine—Dyspepsia—Bupropion—obesity	5.1e-05	0.00129	CcSEcCtD
Pseudoephedrine—Decreased appetite—Bupropion—obesity	5.04e-05	0.00128	CcSEcCtD
Pseudoephedrine—Pain—Bupropion—obesity	4.96e-05	0.00126	CcSEcCtD
Pseudoephedrine—Asthenia—Orlistat—obesity	4.93e-05	0.00125	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Bupropion—obesity	4.78e-05	0.00121	CcSEcCtD
Pseudoephedrine—Asthenia—Sibutramine—obesity	4.77e-05	0.00121	CcSEcCtD
Pseudoephedrine—Ephedrine—BCHE—obesity	4.71e-05	0.0401	CrCbGaD
Pseudoephedrine—Phenylpropanolamine—DRD1—obesity	4.65e-05	0.0397	CrCbGaD
Pseudoephedrine—CYP2D6—liver—obesity	4.64e-05	0.00399	CbGeAlD
Pseudoephedrine—Body temperature increased—Bupropion—obesity	4.58e-05	0.00116	CcSEcCtD
Pseudoephedrine—Dizziness—Orlistat—obesity	4.55e-05	0.00115	CcSEcCtD
Pseudoephedrine—Tension—Topiramate—obesity	4.44e-05	0.00113	CcSEcCtD
Pseudoephedrine—Dizziness—Sibutramine—obesity	4.4e-05	0.00112	CcSEcCtD
Pseudoephedrine—Nervousness—Topiramate—obesity	4.4e-05	0.00112	CcSEcCtD
Pseudoephedrine—Vomiting—Orlistat—obesity	4.37e-05	0.00111	CcSEcCtD
Pseudoephedrine—Muscle spasms—Topiramate—obesity	4.35e-05	0.0011	CcSEcCtD
Pseudoephedrine—Rash—Orlistat—obesity	4.33e-05	0.0011	CcSEcCtD
Pseudoephedrine—Dermatitis—Orlistat—obesity	4.33e-05	0.0011	CcSEcCtD
Pseudoephedrine—Phenylpropanolamine—ADRB1—obesity	4.32e-05	0.0368	CrCbGaD
Pseudoephedrine—Headache—Orlistat—obesity	4.31e-05	0.00109	CcSEcCtD
Pseudoephedrine—Tremor—Topiramate—obesity	4.24e-05	0.00108	CcSEcCtD
Pseudoephedrine—Vomiting—Sibutramine—obesity	4.23e-05	0.00107	CcSEcCtD
Pseudoephedrine—Rash—Sibutramine—obesity	4.19e-05	0.00106	CcSEcCtD
Pseudoephedrine—Dermatitis—Sibutramine—obesity	4.19e-05	0.00106	CcSEcCtD
Pseudoephedrine—Headache—Sibutramine—obesity	4.17e-05	0.00106	CcSEcCtD
Pseudoephedrine—Asthenia—Bupropion—obesity	4.16e-05	0.00106	CcSEcCtD
Pseudoephedrine—Agitation—Topiramate—obesity	4.16e-05	0.00106	CcSEcCtD
Pseudoephedrine—Nausea—Orlistat—obesity	4.08e-05	0.00104	CcSEcCtD
Pseudoephedrine—Vertigo—Topiramate—obesity	4.07e-05	0.00103	CcSEcCtD
Pseudoephedrine—Ephedrine—ADRB2—obesity	4.05e-05	0.0345	CrCbGaD
Pseudoephedrine—Palpitations—Topiramate—obesity	4e-05	0.00101	CcSEcCtD
Pseudoephedrine—Nausea—Sibutramine—obesity	3.95e-05	0.001	CcSEcCtD
Pseudoephedrine—Hypertension—Topiramate—obesity	3.91e-05	0.000991	CcSEcCtD
Pseudoephedrine—Chest pain—Topiramate—obesity	3.85e-05	0.000978	CcSEcCtD
Pseudoephedrine—Anxiety—Topiramate—obesity	3.84e-05	0.000974	CcSEcCtD
Pseudoephedrine—Dizziness—Bupropion—obesity	3.83e-05	0.000973	CcSEcCtD
Pseudoephedrine—Confusional state—Topiramate—obesity	3.73e-05	0.000945	CcSEcCtD
Pseudoephedrine—Vomiting—Bupropion—obesity	3.69e-05	0.000935	CcSEcCtD
Pseudoephedrine—Rash—Bupropion—obesity	3.66e-05	0.000927	CcSEcCtD
Pseudoephedrine—Dermatitis—Bupropion—obesity	3.65e-05	0.000927	CcSEcCtD
Pseudoephedrine—Headache—Bupropion—obesity	3.63e-05	0.000921	CcSEcCtD
Pseudoephedrine—Phenylpropanolamine—ADRB2—obesity	3.63e-05	0.031	CrCbGaD
Pseudoephedrine—Tachycardia—Topiramate—obesity	3.61e-05	0.000915	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Topiramate—obesity	3.57e-05	0.000906	CcSEcCtD
Pseudoephedrine—Anorexia—Topiramate—obesity	3.52e-05	0.000893	CcSEcCtD
Pseudoephedrine—Nausea—Bupropion—obesity	3.44e-05	0.000874	CcSEcCtD
Pseudoephedrine—Insomnia—Topiramate—obesity	3.34e-05	0.000848	CcSEcCtD
Pseudoephedrine—Dyspnoea—Topiramate—obesity	3.29e-05	0.000835	CcSEcCtD
Pseudoephedrine—Dyspepsia—Topiramate—obesity	3.25e-05	0.000825	CcSEcCtD
Pseudoephedrine—Decreased appetite—Topiramate—obesity	3.21e-05	0.000815	CcSEcCtD
Pseudoephedrine—Pain—Topiramate—obesity	3.16e-05	0.000801	CcSEcCtD
Pseudoephedrine—Atomoxetine—HTR1B—obesity	3.05e-05	0.026	CrCbGaD
Pseudoephedrine—Feeling abnormal—Topiramate—obesity	3.04e-05	0.000772	CcSEcCtD
Pseudoephedrine—Phentermine—SLC6A4—obesity	2.94e-05	0.0251	CrCbGaD
Pseudoephedrine—Body temperature increased—Topiramate—obesity	2.92e-05	0.000741	CcSEcCtD
Pseudoephedrine—Benzyl alcohol—CYP2E1—obesity	2.71e-05	0.0231	CrCbGaD
Pseudoephedrine—Asthenia—Topiramate—obesity	2.65e-05	0.000672	CcSEcCtD
Pseudoephedrine—Selegiline—CYP2E1—obesity	2.6e-05	0.0222	CrCbGaD
Pseudoephedrine—Atomoxetine—HTR2C—obesity	2.49e-05	0.0212	CrCbGaD
Pseudoephedrine—Dizziness—Topiramate—obesity	2.44e-05	0.00062	CcSEcCtD
Pseudoephedrine—Vomiting—Topiramate—obesity	2.35e-05	0.000596	CcSEcCtD
Pseudoephedrine—Rash—Topiramate—obesity	2.33e-05	0.000591	CcSEcCtD
Pseudoephedrine—Dermatitis—Topiramate—obesity	2.33e-05	0.00059	CcSEcCtD
Pseudoephedrine—Headache—Topiramate—obesity	2.31e-05	0.000587	CcSEcCtD
Pseudoephedrine—Amphetamine—SLC6A4—obesity	2.26e-05	0.0193	CrCbGaD
Pseudoephedrine—Amphetamine—DRD2—obesity	2.25e-05	0.0192	CrCbGaD
Pseudoephedrine—Nausea—Topiramate—obesity	2.19e-05	0.000557	CcSEcCtD
Pseudoephedrine—Methamphetamine—SLC6A4—obesity	2.09e-05	0.0179	CrCbGaD
Pseudoephedrine—Atomoxetine—SLC6A4—obesity	2.06e-05	0.0176	CrCbGaD
Pseudoephedrine—Atomoxetine—HTR2A—obesity	1.58e-05	0.0135	CrCbGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GNAS—obesity	6.93e-07	1.68e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SREBF1—obesity	6.9e-07	1.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3R1—obesity	6.89e-07	1.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IRS2—obesity	6.86e-07	1.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AGT—obesity	6.85e-07	1.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CD36—obesity	6.84e-07	1.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SOCS1—obesity	6.84e-07	1.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOB—obesity	6.79e-07	1.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CD—obesity	6.78e-07	1.64e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3R1—obesity	6.77e-07	1.64e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NOS3—obesity	6.77e-07	1.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SOCS3—obesity	6.76e-07	1.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LEP—obesity	6.72e-07	1.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOE—obesity	6.72e-07	1.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IRS2—obesity	6.71e-07	1.62e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GOT2—obesity	6.71e-07	1.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AGT—obesity	6.7e-07	1.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CAV1—obesity	6.65e-07	1.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOA1—obesity	6.64e-07	1.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL5—obesity	6.63e-07	1.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GNB3—obesity	6.62e-07	1.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LEP—obesity	6.57e-07	1.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOE—obesity	6.57e-07	1.59e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—FASN—obesity	6.57e-07	1.59e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—BCHE—obesity	6.54e-07	1.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TYK2—obesity	6.52e-07	1.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CAV1—obesity	6.51e-07	1.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3CB—obesity	6.51e-07	1.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF2—obesity	6.5e-07	1.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOA1—obesity	6.49e-07	1.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MTHFR—obesity	6.49e-07	1.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LPL—obesity	6.48e-07	1.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—RHOA—obesity	6.47e-07	1.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GNAS—obesity	6.44e-07	1.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FOXO1—obesity	6.44e-07	1.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RPS6KB1—obesity	6.42e-07	1.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ESR1—obesity	6.41e-07	1.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3R1—obesity	6.4e-07	1.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARA—obesity	6.36e-07	1.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3CB—obesity	6.36e-07	1.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PRKCB—obesity	6.33e-07	1.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—F2—obesity	6.33e-07	1.53e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP2E1—obesity	6.31e-07	1.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOB—obesity	6.31e-07	1.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PIK3CA—obesity	6.28e-07	1.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ESR1—obesity	6.27e-07	1.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—BAD—obesity	6.26e-07	1.51e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3CB—obesity	6.25e-07	1.51e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NQO1—obesity	6.24e-07	1.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—F2—obesity	6.2e-07	1.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PRKCB—obesity	6.2e-07	1.5e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—obesity	6.19e-07	1.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AGT—obesity	6.16e-07	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL5—obesity	6.16e-07	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—BAD—obesity	6.12e-07	1.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CG—obesity	6.06e-07	1.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOE—obesity	6.04e-07	1.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LPL—obesity	6.02e-07	1.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IRS1—obesity	5.99e-07	1.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CAV1—obesity	5.98e-07	1.45e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCG—obesity	5.98e-07	1.45e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC2A4—obesity	5.98e-07	1.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FOXO1—obesity	5.98e-07	1.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRKCD—obesity	5.97e-07	1.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RPS6KB1—obesity	5.97e-07	1.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOA1—obesity	5.97e-07	1.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CG—obesity	5.93e-07	1.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CB—obesity	5.91e-07	1.43e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYCS—obesity	5.9e-07	1.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IRS1—obesity	5.86e-07	1.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2A—obesity	5.84e-07	1.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—C3—obesity	5.84e-07	1.41e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GGT1—obesity	5.79e-07	1.4e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GOT1—obesity	5.79e-07	1.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—POMC—obesity	5.77e-07	1.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—INS—obesity	5.74e-07	1.39e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NCOA1—obesity	5.71e-07	1.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL2—obesity	5.64e-07	1.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—POMC—obesity	5.64e-07	1.37e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP19A1—obesity	5.62e-07	1.36e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—STK11—obesity	5.62e-07	1.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—INS—obesity	5.61e-07	1.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IRS2—obesity	5.55e-07	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRKCD—obesity	5.55e-07	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—obesity	5.55e-07	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AGT—obesity	5.55e-07	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT2—obesity	5.55e-07	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL2—obesity	5.52e-07	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CG—obesity	5.45e-07	1.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—obesity	5.43e-07	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOE—obesity	5.43e-07	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2A—obesity	5.43e-07	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—obesity	5.43e-07	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT2—obesity	5.42e-07	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—C3—obesity	5.42e-07	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CAV1—obesity	5.38e-07	1.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOA1—obesity	5.37e-07	1.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CD—obesity	5.33e-07	1.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—PIK3CA—obesity	5.28e-07	1.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SERPINE1—obesity	5.27e-07	1.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARG—obesity	5.26e-07	1.27e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—COMT—obesity	5.23e-07	1.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CD—obesity	5.21e-07	1.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ESR1—obesity	5.19e-07	1.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—POMC—obesity	5.19e-07	1.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—PIK3CA—obesity	5.16e-07	1.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IRS2—obesity	5.16e-07	1.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—INS—obesity	5.16e-07	1.25e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNB3—obesity	5.16e-07	1.25e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARGC1A—obesity	5.16e-07	1.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SERPINE1—obesity	5.15e-07	1.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AGT—obesity	5.15e-07	1.25e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HMOX1—obesity	5.13e-07	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—obesity	5.13e-07	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TYK2—obesity	5.13e-07	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PRKCB—obesity	5.12e-07	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—F2—obesity	5.12e-07	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RHOA—obesity	5.08e-07	1.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BAD—obesity	5.06e-07	1.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOE—obesity	5.05e-07	1.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—obesity	5.05e-07	1.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3R1—obesity	5.03e-07	1.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOS3—obesity	5.03e-07	1.22e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNAS—obesity	5.02e-07	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TYK2—obesity	5.01e-07	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CAV1—obesity	5e-07	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOA1—obesity	4.99e-07	1.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RHOA—obesity	4.97e-07	1.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3R1—obesity	4.92e-07	1.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOS3—obesity	4.92e-07	1.19e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOB—obesity	4.92e-07	1.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CG—obesity	4.9e-07	1.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IRS1—obesity	4.85e-07	1.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ESR1—obesity	4.82e-07	1.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PIK3CA—obesity	4.79e-07	1.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CD—obesity	4.79e-07	1.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PRKCB—obesity	4.76e-07	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—F2—obesity	4.76e-07	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—obesity	4.73e-07	1.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BAD—obesity	4.7e-07	1.14e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—LPL—obesity	4.69e-07	1.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PIK3CA—obesity	4.69e-07	1.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—POMC—obesity	4.67e-07	1.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MTOR—obesity	4.64e-07	1.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CB—obesity	4.64e-07	1.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—INS—obesity	4.64e-07	1.12e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GPX1—obesity	4.58e-07	1.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL2—obesity	4.57e-07	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CG—obesity	4.56e-07	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MTOR—obesity	4.54e-07	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CB—obesity	4.54e-07	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3R1—obesity	4.52e-07	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NOS3—obesity	4.52e-07	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IRS1—obesity	4.5e-07	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—obesity	4.49e-07	1.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT2—obesity	4.49e-07	1.09e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CD36—obesity	4.46e-07	1.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—POMC—obesity	4.34e-07	1.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—INS—obesity	4.31e-07	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—obesity	4.31e-07	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CD—obesity	4.31e-07	1.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	4.27e-07	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SERPINE1—obesity	4.26e-07	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—obesity	4.24e-07	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL2—obesity	4.24e-07	1.03e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—obesity	4.23e-07	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—obesity	4.22e-07	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CB—obesity	4.18e-07	1.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—obesity	4.17e-07	1.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT2—obesity	4.17e-07	1.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—obesity	4.15e-07	1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TYK2—obesity	4.15e-07	1e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARA—obesity	4.15e-07	1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—obesity	4.14e-07	1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RHOA—obesity	4.11e-07	9.95e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3R1—obesity	4.07e-07	9.85e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOS3—obesity	4.07e-07	9.85e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—obesity	4.04e-07	9.76e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AGT—obesity	4.02e-07	9.71e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CD—obesity	4.01e-07	9.69e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	3.97e-07	9.6e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SERPINE1—obesity	3.96e-07	9.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—obesity	3.95e-07	9.55e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOE—obesity	3.93e-07	9.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MAPK8—obesity	3.93e-07	9.5e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—obesity	3.91e-07	9.47e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAV1—obesity	3.9e-07	9.43e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOA1—obesity	3.89e-07	9.41e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	3.88e-07	9.38e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TYK2—obesity	3.85e-07	9.32e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MAPK8—obesity	3.84e-07	9.29e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—obesity	3.83e-07	9.26e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RHOA—obesity	3.82e-07	9.25e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3CA—obesity	3.81e-07	9.22e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3R1—obesity	3.78e-07	9.15e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOS3—obesity	3.78e-07	9.15e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CB—obesity	3.76e-07	9.09e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MTOR—obesity	3.76e-07	9.09e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	3.6e-07	8.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT3—obesity	3.59e-07	8.68e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CG—obesity	3.55e-07	8.59e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT3—obesity	3.51e-07	8.49e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CB—obesity	3.49e-07	8.45e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MTOR—obesity	3.49e-07	8.45e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—obesity	3.49e-07	8.44e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—obesity	3.43e-07	8.31e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARG—obesity	3.43e-07	8.29e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—POMC—obesity	3.38e-07	8.18e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—INS—obesity	3.36e-07	8.13e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—obesity	3.33e-07	8.07e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—obesity	3.33e-07	8.05e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—obesity	3.27e-07	7.9e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—obesity	3.26e-07	7.89e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—obesity	3.25e-07	7.87e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—obesity	3.24e-07	7.84e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—obesity	3.19e-07	7.72e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAPK8—obesity	3.18e-07	7.68e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—obesity	3.17e-07	7.66e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CD—obesity	3.12e-07	7.55e-06	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—obesity	3.11e-07	7.53e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—obesity	3.08e-07	7.45e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—obesity	3.03e-07	7.34e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAPK8—obesity	2.95e-07	7.14e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3R1—obesity	2.95e-07	7.13e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NOS3—obesity	2.95e-07	7.13e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—obesity	2.94e-07	7.12e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT3—obesity	2.9e-07	7.02e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CA—obesity	2.83e-07	6.85e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CA—obesity	2.77e-07	6.7e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CB—obesity	2.72e-07	6.58e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—obesity	2.7e-07	6.53e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT3—obesity	2.7e-07	6.53e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—obesity	2.7e-07	6.52e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—obesity	2.69e-07	6.51e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CA—obesity	2.55e-07	6.16e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—obesity	2.51e-07	6.07e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—obesity	2.51e-07	6.06e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—obesity	2.5e-07	6.05e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—obesity	2.45e-07	5.93e-06	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—obesity	2.31e-07	5.59e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.29e-07	5.54e-06	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—obesity	2.26e-07	5.47e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CA—obesity	2.13e-07	5.15e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—obesity	2.08e-07	5.03e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—obesity	2.03e-07	4.91e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—obesity	1.88e-07	4.56e-06	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—obesity	1.87e-07	4.53e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—obesity	1.74e-07	4.21e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CA—obesity	1.66e-07	4.01e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—obesity	1.35e-07	3.28e-06	CbGpPWpGaD
